Skip to main content
SpringerLink
Log in

Insulin resistance is associated with cognitive decline in type 1 diabetes mellitus

  • Short Communication
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jacobson AM, Ryan CM, Cleary PA et al (2011) Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the diabetes control and complications trial (DCCT) cohort. Diabetologia 54(2):245–255

    Article  CAS  Google Scholar 

  2. Jacobson AM, Ryan CM, Braffett BH et al (2021) Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study. Lancet Diabetes Endocrinol 9(7):436–445

    Article  Google Scholar 

  3. Tam CS, Xie W, Johnson WD et al (2012) Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 35(7):1605–1610

    Article  CAS  Google Scholar 

  4. Blazquez E, Velazquez E, Hurtado-Carneiro V, Ruiz-Albusac JM (2014) Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer’s disease. Front Endocrinol (Lausanne) 5:161

    Article  Google Scholar 

  5. Samaras K, Makkar S, Crawford JD et al (2020) Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: the sydney memory and ageing study. Diabetes Care 43(11):2691–2701

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The Diabetes Control and Complications Trial (DCCT) and its follow-up the Epidemiology of Diabetes Interventions and Complications (EDIC) study were conducted by the DCCT/EDIC Research Group and supported by National Institute of Health grants and contracts and by the General Clinical Research Center Program, NCRR. The data from the DCCT/EDIC study were supplied by the NIDDK Central Repositories. This manuscript was not prepared under the auspices of the DCCT/EDIC study and does not represent analyses or conclusions of the DCCT/EDIC study group, the NIDDK Central Repositories, or the NIH.

Author information

Authors and Affiliations

  1. Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Parks Hall 148, Athens, OH, 45701, USA

    Yuanjie Mao

  2. Endocrinology Clinic, OhioHealth Castrop Health Center, Athens, OH, 45701, USA

    Yuanjie Mao

  3. Merck Research Labs, Merck & Co., Inc, West Point, PA, 19486, USA

    Wenjun Zhong

Authors
  1. Yuanjie Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenjun Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Y.M. designed the study, conduct data analysis, and wrote the manuscript. W.Z. conduct data analysis and wrote results.

Corresponding author

Correspondence to Yuanjie Mao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All studies were conducted in accordance with principles for human experimentation as defined in the Declaration of Helsinki, and approved by the relevant institutional review boards.

Informed consent

Informed consent is not applicable.

Additional information

Managed by Massimo Porta.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 121 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mao, Y., Zhong, W. Insulin resistance is associated with cognitive decline in type 1 diabetes mellitus. Acta Diabetol 59, 571–573 (2022). https://doi.org/10.1007/s00592-021-01846-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-021-01846-z

Keywords

Search

Navigation